Clinical Trial

A Diagnostic Test for Dementia With Lewy Bodies

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 15, 2025 (before its estimated September 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
The Syn-D Study will be evaluating α-synuclein in patients with suspected MCI-AD and MCI-DLB. Using a simple diagnostic test will improve clinical accuracy in diagnosing, earlier diagnosis, and distinguish between neurodegenerative diseases.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-07-26; most recent amendment 2025-01-13.
Status change: Recruiting → Active, Not Recruiting 2025-01-13
Status change: Not Yet Recruiting → Recruiting 2023-03-06
Trial Details
NCT Number NCT05479552
Lead Sponsor CND Life Sciences
Collaborators: National Institute on Aging (NIA)
Conditions MCI-AD, Early Stage Alzheimer's Disease, MCI-DLB, Early Stage Dementia With Lewy Bodies
Enrollment 80 participants
Start Date 2022-08-15
Primary Completion 2025-09-28 (estimated)
Study Completion 2025-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-15